Clinical

CROs under pressure as early-stage pipelines dry up

There was a sharp slowdown in pharmaceutical outsourcing in the last six months which “really caught a lot of people by surprise”, according to Jim Miller of outsourcing consultancy PharmSource, in his annual review of the sector at the Interphex show in New York.
For the contract research industry, which spans clinical research and early R&D [...]

Quintiles chief sees opportunities

Quintiles Transnational, the Durham company that helps drugmakers test and sell new medicines, gets its business from an industry that is trying to ensure its future by shrinking and consolidating.
Drug development is also undergoing significant changes. But Dennis Gillings, Quintiles’ founder and chief executive, sees opportunity as GlaxoSmithKline cuts costs and jobs, Pfizer buys Wyeth [...]

About ChinaR&D Reader | Copyright © 2009